Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease.
Guidi L, Pugliese D, Panici Tonucci T, Bertani L, Costa F, Privitera G, Tolusso B, Di Mario C, Albano E, Tapete G, Gremese E, Papa A, Gasbarrini A, Rapaccini GL, Armuzzi A. Guidi L, et al. Among authors: tapete g. United European Gastroenterol J. 2019 Nov;7(9):1189-1197. doi: 10.1177/2050640619873784. Epub 2019 Sep 3. United European Gastroenterol J. 2019. PMID: 31700632 Free PMC article.
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab.
Bertani L, Fornai M, Fornili M, Antonioli L, Benvenuti L, Tapete G, Baiano Svizzero G, Ceccarelli L, Mumolo MG, Baglietto L, de Bortoli N, Bellini M, Marchi S, Costa F, Blandizzi C. Bertani L, et al. Among authors: tapete g. Aliment Pharmacol Ther. 2020 Jul;52(2):284-291. doi: 10.1111/apt.15870. Epub 2020 Jun 7. Aliment Pharmacol Ther. 2020. PMID: 32506635 Clinical Trial.
Fecal Calprotectin Predicts Mucosal Healing in Patients With Ulcerative Colitis Treated With Biological Therapies: A Prospective Study.
Bertani L, Blandizzi C, Mumolo MG, Ceccarelli L, Albano E, Tapete G, Baiano Svizzero G, Zanzi F, Coppini F, de Bortoli N, Bellini M, Morganti R, Marchi S, Costa F. Bertani L, et al. Among authors: tapete g. Clin Transl Gastroenterol. 2020 May;11(5):e00174. doi: 10.14309/ctg.0000000000000174. Clin Transl Gastroenterol. 2020. PMID: 32677804 Free PMC article.
Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry.
Tapete G, Bertani L, Pieraccini A, Lynch EN, Giannotta M, Morganti R, Biviano I, Naldini S, Mumolo MG, De Nigris F, Calella F, Bagnoli S, Minciotti M, Maltinti S, Rentini S, Ceccarelli L, Lionetti P, Milla M, Costa F. Tapete G, et al. Inflamm Bowel Dis. 2022 Jan 5;28(1):62-69. doi: 10.1093/ibd/izab027. Inflamm Bowel Dis. 2022. PMID: 33570142
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients.
Bertani L, Baglietto L, Antonioli L, Fornai M, Tapete G, Albano E, Ceccarelli L, Mumolo MG, Pellegrini C, Lucenteforte E, de Bortoli N, Bellini M, Marchi S, Blandizzi C, Costa F. Bertani L, et al. Among authors: tapete g. Br J Clin Pharmacol. 2020 Jul;86(7):1296-1305. doi: 10.1111/bcp.14235. Epub 2020 Feb 18. Br J Clin Pharmacol. 2020. PMID: 32027388 Free PMC article.
Novel Prognostic Biomarkers of Mucosal Healing in Ulcerative Colitis Patients Treated With Anti-TNF: Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio.
Bertani L, Rossari F, Barberio B, Demarzo MG, Tapete G, Albano E, Baiano Svizzero G, Ceccarelli L, Mumolo MG, Brombin C, de Bortoli N, Bellini M, Marchi S, Bodini G, Savarino E, Costa F. Bertani L, et al. Among authors: tapete g. Inflamm Bowel Dis. 2020 Sep 18;26(10):1579-1587. doi: 10.1093/ibd/izaa062. Inflamm Bowel Dis. 2020. PMID: 32232392
16 results